Frequency, Predictors, and Outcomes of Drug-Eluting Stent Utilization in Patients With High-Risk Non–ST-Segment Elevation Acute Coronary Syndromes
David E. Kandzari(Piedmont Atlanta Hospital), Eric D. Peterson(The University of Texas Southwestern Medical Center), Robert A. Harrington(Clinical Research Institute), Sidney C. Smith(University of North Carolina at Chapel Hill), Anita Y. Chen(University of Rochester Medicine), Barbara L. Lytle(Duke University), David J. Cohen(Baim Institute for Clinical Research), E. Magnus Ohman(Duke University), Sarah Milford–Beland(Clinical Research Institute), W. Brian Gibler(University of Cincinnati), Matthew T. Roe(Clinical Research Institute)
Cited by 70
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k